Clinical Trial Update: Evaluation of Preoperative N1539 in Total Knee Arthroplasty [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating preoperative N1539 in total knee arthroplasty has completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain Postoperative
• Total Knee Arthroplasty-related Pain

Drugs mentioned

• N1539

Snippet

Sponsor: Baudax Bio | Conditions: Pain, Postoperative | Phase 3 | Status: COMPLETED | Results posted: 2023-05-25